Governance Summit Therapeutics Inc.

SMMT

US86627T1088

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 17:20:00 10/02/2026 GMT			5-day change	1st Jan Change
15.45 ^USD	+3.21%		+5.79%	-11.75%

01-29	Sector Update: Health Care Stocks Edge Higher Premarket Thursday	MT
01-29	Summit Therapeutics Announces U.S. FDA Acceptance of Biologics License Application Seeking Approval for Ivonescimab in Combination with Chemotherapy in Treatment of Patients with EGFRm NSCLC Post-TKI Therapy	CI

Executive Committee: Summit Therapeutics Inc.

Manager

Positions heldSince

Robert Duggan

81 year

Chief Executive Officer

31/03/2020

Howard West

Chief Tech/Sci/R&D Officer

18/10/2023

Allen Yang

58 year

Chief Tech/Sci/R&D Officer

15/10/2023

Bhaskar Anand

48 year

Comptroller/Controller/Auditor

01/04/2024

Manmeet Singh Soni

48 year

Chief Operating Officer	15/10/2023
Director of Finance/CFO	01/04/2024

Urte Gayko

55 year

General Counsel

15/10/2023

Dave Gancarz

Investor Relations Contact

31/10/2020

Mahkam Zanganeh

54 year

Chief Executive Officer	24/07/2022
President	24/07/2022

Composition of the Board of Directors: Summit Therapeutics Inc.

Director

CommitteesSince

Robert Duggan

81 year

Compensation Committee	01/11/2017
Governance Committee	01/11/2017
Nominating Committee	01/11/2017

Manmeet Singh Soni

48 year

Audit Committee Chair	23/12/2019
Compensation Committee Chair	23/12/2019
Governance Committee Chair
Nominating Committee Chair
Governance Committee	23/12/2019
Nominating Committee	23/12/2019

Kenneth Clark

67 year

Audit Committee Chair
Compensation Committee Chair
Governance Committee Chair
Nominating Committee Chair

Jeffrey Huber

57 year

Audit Committee	01/07/2012
Governance Committee	15/11/2021
Nominating Committee	15/11/2021
Audit Committee Chair	26/06/2024

Robert Booth

72 year

Audit Committee
Governance Committee	27/09/2022
Nominating Committee	27/09/2022

Alessandra Cesano

65 year

Governance Committee	07/02/2024
Nominating Committee	07/02/2024

Michelle Xia

59 year

Compensation Committee	15/11/2019
Nominating Committee Chair	15/11/2019

Mostafa Ronaghi

57 year

Audit Committee	10/04/2024
Compensation Committee	10/04/2024

Mahkam Zanganeh

54 year

Director/Board Member

10/11/2020

Latest Appointments: Summit Therapeutics Inc.

02-09	Avacta appoints new chief scientific officer, plans clinical trials	AN
02-09	Avacta Therapeutics Announces Executive Changes	CI
18/03/25	Summit Therapeutics Names Robert LaCaze as Chief Commercial Officer	MT
17/03/25	Robert LaCaze Joins Summit Therapeutics Inc. as Chief Commercial Officer	CI
27/06/24	Summit Therapeutics Inc. Appoints Jeff Huber to Its Board of Directors	CI
24/06/24	Akebia Therapeutics, Inc. Appoints Erik Ostrowski as Senior Vice President and Chief Business Officer	CI
24/06/24	Akebia Therapeutics, Inc. Appoints Erik Ostrowski as Chief Financial Officer	CI

More news

Former Officers and Directors: Summit Therapeutics Inc.

Insider

Positions held

SinceUntil

Campbell Hair

Human Resources Officer

30/09/2020

28/02/2025

Ujwala Mahatme

Director/Board Member	12/07/2020	11/06/2024
Independent Dir/Board Member	12/07/2020	11/06/2024

Ankur Dhingra

Comptroller/Controller/Auditor	30/05/2022	01/04/2024
Director of Finance/CFO	30/05/2022	01/04/2024

Laura Chow

Chief Tech/Sci/R&D Officer

02/11/2023

01/01/2024

Elaine C. Stracker

General Counsel

31/08/2023

Erik Poulsen

General Counsel

31/12/2020

30/04/2022

Priyanka Mandava

Chief Tech/Sci/R&D Officer

28/02/2021

28/02/2022

Jeffrey R. Maranian

Comptroller/Controller/Auditor

31/10/2020

20/01/2022

Camilla Graham

Chief Tech/Sci/R&D Officer

30/11/2021

David Powell

Chief Tech/Sci/R&D Officer

29/02/2020

30/11/2021

Michael Donaldson

Director of Finance/CFO

30/04/2020

01/07/2021

Michael Wang

Director/Board Member

25/02/2021

27/04/2021

Jos Houbiers

Chief Tech/Sci/R&D Officer

30/06/2020

31/03/2021

Ventzislav Kirilov Stefanov

Director/Board Member

10/11/2020

Ramses Erdtmann

Director/Board Member	16/04/2020	-
Independent Dir/Board Member	16/04/2020	-

Stephanie Bewick

Corporate Officer/Principal

Will Black

Chief Tech/Sci/R&D Officer

Danelle James

Chief Tech/Sci/R&D Officer

Margaret Wasilewski

Chief Tech/Sci/R&D Officer

Glyn Owain Edwards

Director/Board Member	-	-
Chief Executive Officer	-	-

Age distribution of managers

Parity Men Women

Male	19
Female	1

Of which Executive Committee

Male	8
Female	0

Of which Directors

Male	9
Female	0

Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of patient, physician and caregiver medicinal therapies. The Company's development candidate is ivonescimab, a potential first-in-class bispecific antibody intending to combine the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF compound into a single molecule. It develops ivonescimab in non-small cell lung cancer (NSCLC), specifically launching Phase III clinical trials in the indications such as ivonescimab combined with chemotherapy in patients with epidermal growth factor receptor (EGFR)-mutated, locally advanced or metastatic non-squamous NSCLC who have progressed after treatment with a third-generation EGFR tyrosine kinase inhibitor (HARMONi), and ivonescimab combined with chemotherapy in first-line metastatic squamous NSCLC patients (HARMONi-3). Its ivonescimab is engineered with Akeso's Tetrabody technology.

Employees

159

Sector

Biotechnology & Medical Research

Calendar

03-11 - Q4 2025 Earnings Release (Projected)

More about the company